Santen Pharmaceutical Co. Ltd. announced the change of position of Sadatoshi Furukado from Member of the Board, Vice President, Executive Corporate Officer Japan Business and Human Resources Development to Member of the Board, Vice President, Executive Corporate Officer Human Resources Development and Corporate Administration. Designation of Akihiro Tsujimura will be changed from Senior Corporate Officer Head of Asia Division to Executive Corporate Officer, Head of Corporate Development Division and Asia and North America Businesses.

Designation of Masamichi Sato will be changed from Senior Corporate Officer Corporate Development and Head of CSR & General Affairs Division to Senior Corporate Officer and Head of CSR & General Affairs Division. Designation of Shigeo Taniuchi will be changed from Corporate Officer and Head of Santen Europe to Senior Corporate Officer and Head of Santen Europe. Designation of Kenji Morishima will be changed from Corporate Officer, Head of Global Pharmaceutical Technology Development to Corporate Officer and Head of Pharmaceutical Technology Development.

Designation of Akio Kimura will be changed from Corporate Officer and Head of Global Quality Compliance to Corporate Officer and Head of Global Product Supply and Head of Global Quality Compliance. Designation of Satoshi Suzuki will be changed from Manager, Asia Division to Corporate Officer and Head of Asia Division.